piretanide has been researched along with Cardiac Failure in 16 studies
piretanide: potent inhibitor of chloride transport; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the acute and chronic effects of diuretic monotherapy with 3 mg piretanide bid, 46 patients (pts) with congestive heart failure (NYHA II-III) secondary to coronary artery disease were studied." | 9.06 | Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial. ( Bauer, U; Cernoch, K; Fehske, KJ; Haerer, W; Hetzel, M; Hombach, V; Mouselimis, N; Stauch, M; Sultan, N, 1990) |
| "A double-blind parallel group study was carried out to compare the effects of piretanide on daily glucose profiles, symptoms of congestive heart failure and serum electrolytes with those of furosemide in 24 diabetic in-patients suffering from congestive heart failure." | 9.06 | The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. ( Car, N; Skrabalo, Z; Verho, M, 1988) |
| "The diuretic and clinical efficacy and safety of piretanide, a new high-ceiling loop diuretic, was determined in patients with mild to moderately severe congestive heart failure." | 9.06 | Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure. ( Baumgardner, S; Chardo, F; Charuzi, Y; Kim, CS; Liang, CS; Sherman, LG, 1986) |
| "Piretanide, a diuretic that acts on the loop of Henle, was used to treat patients with cardiac failure." | 9.05 | Comparison of piretanide and chlorothiazide in the treatment of cardiac failure. ( Gillies, A; Morgan, T; Myers, J, 1980) |
| "The effects of piretanide and a hydrochlorothiazide (HCT)-triamterene combination were compared in an open, controlled, randomised study on two groups of 15 patients, aged 42-74 years, with congestive heart failure (NYHA II-III)." | 9.05 | [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene]. ( Gonska, BD; Kreuzer, H, 1985) |
| "In a randomized double-blind, parallel group study, the effects of piretanide on serum electrolytes and on symptoms of congestive heart failure were compared with those of the combination piretanide plus triamterene in out-patients with mild to severe congestive heart failure." | 9.05 | The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure. ( Bückert, C; Freude, J; Jaeger, S; Pahnke, K; Verho, M, 1985) |
| "1 This study has compared the diuresis produced by a single oral administration of 6 mg piretanide, 9 mg piretanide and 1 mg bumetanide in a group of nine patients with cardiac failure using a balanced randomized design." | 9.04 | A single dose comparison of piretanide and bumetanide in congestive cardiac failure. ( Dombey, SL; Homeida, M; Roberts, CJ, 1979) |
| "The efficacy and pharmacokinetics of the diuretic piretanide were studied in two groups of six patients hospitalized for congestive heart failure." | 7.67 | Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure. ( Frey, F; Lahn, W; Marone, C; Rivera, B; Zwahlen, H, 1989) |
| "Eight patients with chronic heart failure classified as NYHA class II to III (group 1) and nine patients with acute decompensated heart failure classified as NYHA class IV (group 2) were treated with piretanide at a dosage of 12 mg administered intravenously." | 7.67 | [Piretanide in chronic and acute decompensated heart failure. Effect on hemodynamics and vasoactive hormones]. ( Hopf, R; Kaltenbach, M; Kirsten, R; Nelson, K; Pooth, R; Sievert, H; Vens-Cappell, F, 1989) |
| " The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure." | 7.67 | Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988) |
| "The haemodynamic effect of a single 12 mg intravenous dose of piretanide was assessed in 11 patients with congestive heart failure." | 7.66 | Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure. ( Apoil, E; Hébert, JL; Valette, H, 1983) |
| "To evaluate the acute and chronic effects of diuretic monotherapy with 3 mg piretanide bid, 46 patients (pts) with congestive heart failure (NYHA II-III) secondary to coronary artery disease were studied." | 5.06 | Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial. ( Bauer, U; Cernoch, K; Fehske, KJ; Haerer, W; Hetzel, M; Hombach, V; Mouselimis, N; Stauch, M; Sultan, N, 1990) |
| "A double-blind parallel group study was carried out to compare the effects of piretanide on daily glucose profiles, symptoms of congestive heart failure and serum electrolytes with those of furosemide in 24 diabetic in-patients suffering from congestive heart failure." | 5.06 | The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. ( Car, N; Skrabalo, Z; Verho, M, 1988) |
| "The diuretic and clinical efficacy and safety of piretanide, a new high-ceiling loop diuretic, was determined in patients with mild to moderately severe congestive heart failure." | 5.06 | Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure. ( Baumgardner, S; Chardo, F; Charuzi, Y; Kim, CS; Liang, CS; Sherman, LG, 1986) |
| "Piretanide, a diuretic that acts on the loop of Henle, was used to treat patients with cardiac failure." | 5.05 | Comparison of piretanide and chlorothiazide in the treatment of cardiac failure. ( Gillies, A; Morgan, T; Myers, J, 1980) |
| "The effects of piretanide and a hydrochlorothiazide (HCT)-triamterene combination were compared in an open, controlled, randomised study on two groups of 15 patients, aged 42-74 years, with congestive heart failure (NYHA II-III)." | 5.05 | [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene]. ( Gonska, BD; Kreuzer, H, 1985) |
| "In a randomized double-blind, parallel group study, the effects of piretanide on serum electrolytes and on symptoms of congestive heart failure were compared with those of the combination piretanide plus triamterene in out-patients with mild to severe congestive heart failure." | 5.05 | The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure. ( Bückert, C; Freude, J; Jaeger, S; Pahnke, K; Verho, M, 1985) |
| "1 This study has compared the diuresis produced by a single oral administration of 6 mg piretanide, 9 mg piretanide and 1 mg bumetanide in a group of nine patients with cardiac failure using a balanced randomized design." | 5.04 | A single dose comparison of piretanide and bumetanide in congestive cardiac failure. ( Dombey, SL; Homeida, M; Roberts, CJ, 1979) |
| "The efficacy and pharmacokinetics of the diuretic piretanide were studied in two groups of six patients hospitalized for congestive heart failure." | 3.67 | Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure. ( Frey, F; Lahn, W; Marone, C; Rivera, B; Zwahlen, H, 1989) |
| "Eight patients with chronic heart failure classified as NYHA class II to III (group 1) and nine patients with acute decompensated heart failure classified as NYHA class IV (group 2) were treated with piretanide at a dosage of 12 mg administered intravenously." | 3.67 | [Piretanide in chronic and acute decompensated heart failure. Effect on hemodynamics and vasoactive hormones]. ( Hopf, R; Kaltenbach, M; Kirsten, R; Nelson, K; Pooth, R; Sievert, H; Vens-Cappell, F, 1989) |
| " The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure." | 3.67 | Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988) |
| "The influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide was investigated in nine patients with congestive heart failure." | 3.67 | Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide. ( Hasenfuss, G; Herzog, C; Holubarsch, C; Just, H; Knauf, H; Mutschler, E; Spahn, H, 1987) |
| "The haemodynamic effect of a single 12 mg intravenous dose of piretanide was assessed in 11 patients with congestive heart failure." | 3.66 | Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure. ( Apoil, E; Hébert, JL; Valette, H, 1983) |
| "Piretanide is a potent 'loop' diuretic whose principal site of action is in the thick ascending limb of the loop of Henle." | 2.37 | Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. ( Brogden, RN; Clissold, SP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (87.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doglio, GR | 1 |
| Pusajó, JF | 1 |
| Bonfigli, G | 1 |
| Hualde, R | 1 |
| Lafourcade, ES | 1 |
| Ortiz Maldonado, HG | 1 |
| Schöpp, W | 1 |
| Valette, H | 1 |
| Hébert, JL | 1 |
| Apoil, E | 1 |
| Gillies, A | 1 |
| Morgan, T | 1 |
| Myers, J | 1 |
| Silke, B | 1 |
| Homeida, M | 1 |
| Roberts, CJ | 1 |
| Dombey, SL | 1 |
| Haerer, W | 1 |
| Bauer, U | 1 |
| Sultan, N | 1 |
| Cernoch, K | 1 |
| Mouselimis, N | 1 |
| Fehske, KJ | 1 |
| Hetzel, M | 1 |
| Stauch, M | 1 |
| Hombach, V | 1 |
| Marone, C | 1 |
| Rivera, B | 1 |
| Zwahlen, H | 1 |
| Lahn, W | 1 |
| Frey, F | 1 |
| Sievert, H | 1 |
| Hopf, R | 1 |
| Vens-Cappell, F | 1 |
| Kirsten, R | 1 |
| Nelson, K | 1 |
| Pooth, R | 1 |
| Kaltenbach, M | 1 |
| McNabb, WR | 1 |
| Noormohamed, FH | 1 |
| Lant, AF | 1 |
| Car, N | 1 |
| Skrabalo, Z | 1 |
| Verho, M | 2 |
| Sherman, LG | 1 |
| Liang, CS | 1 |
| Baumgardner, S | 1 |
| Charuzi, Y | 1 |
| Chardo, F | 1 |
| Kim, CS | 1 |
| Hasenfuss, G | 1 |
| Holubarsch, C | 1 |
| Herzog, C | 1 |
| Knauf, H | 1 |
| Spahn, H | 1 |
| Mutschler, E | 1 |
| Just, H | 1 |
| Clissold, SP | 1 |
| Brogden, RN | 1 |
| Gonska, BD | 1 |
| Kreuzer, H | 1 |
| Bückert, C | 1 |
| Freude, J | 1 |
| Jaeger, S | 1 |
| Pahnke, K | 1 |
2 reviews available for piretanide and Cardiac Failure
| Article | Year |
|---|---|
Central hemodynamic effects of diuretic therapy in chronic heart failure.
Topics: Bumetanide; Cardiac Output; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Mu | 1993 |
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Topics: Angina Pectoris; Animals; Blood Glucose; Diuretics; Dogs; Edema; Heart Failure; Humans; Hypertension | 1985 |
7 trials available for piretanide and Cardiac Failure
| Article | Year |
|---|---|
Comparison of piretanide and chlorothiazide in the treatment of cardiac failure.
Topics: Adult; Aged; Body Weight; Chlorothiazide; Clinical Trials as Topic; Diuretics; Heart Failure; Humans | 1980 |
A single dose comparison of piretanide and bumetanide in congestive cardiac failure.
Topics: Aged; Bumetanide; Calcium; Clinical Trials as Topic; Diuretics; Female; Heart Failure; Humans; Male; | 1979 |
Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial.
Topics: Adult; Aged; Catheterization, Swan-Ganz; Diuretics; Echocardiography; Exercise Test; Female; Heart F | 1990 |
The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diur | 1988 |
Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure.
Topics: Adult; Aged; Clinical Trials as Topic; Diuresis; Diuretics; Double-Blind Method; Female; Heart Failu | 1986 |
[Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Drug Combinations; Female | 1985 |
The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuretics; Double-Blind Method; | 1985 |
7 other studies available for piretanide and Cardiac Failure
| Article | Year |
|---|---|
[Effect of a loop diuretic, piretanide, in severe cardiac insufficiency].
Topics: Diuresis; Diuretics; Female; Heart Failure; Hemodynamics; Humans; Male; Potassium; Sodium; Sulfonami | 1984 |
[Chronic cardiac insufficiency. Treatment with a vasoactive diuretic. Effectiveness and tolerance of piretanide (Arelix mite)].
Topics: Adult; Aged; Diuretics; Female; Heart Failure; Humans; Male; Middle Aged; Sulfonamides | 1983 |
Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Diuretics; Electrolytes; Female; Heart Failure; Hemodynam | 1983 |
Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Diuresis; Diuretics; Female; Heart Failure; Humans; Kidney; Male; Middle Ag | 1989 |
[Piretanide in chronic and acute decompensated heart failure. Effect on hemodynamics and vasoactive hormones].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Catecholamines; Dinoprostone; Diuretics; Female; Heart Fa | 1989 |
Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
Topics: Adult; Aged; Diuretics; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middl | 1988 |
Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.
Topics: Adult; Aged; Chronic Disease; Diuresis; Diuretics; Edema; Female; Heart Failure; Hemodynamics; Human | 1987 |